Want to see VRPX full AI Analyst Report?
Virpax Pharmaceuticals (VRPX) Stock Statistics & Valuation Metrics
Total Valuation
Virpax Pharmaceuticals has a market cap or net worth of $2,485.00. The enterprise value is $4.14M.
- Market Cap
- $2,485.00
- Enterprise Value
- $4.14M
Share Statistics
Virpax Pharmaceuticals has 1,242,504 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,242,504
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
Virpax Pharmaceuticals’s return on equity (ROE) is 13.21 and return on invested capital (ROIC) is 1322.00%.
- Return on Equity (ROE)
- 13.21
- Return on Assets (ROA)
- -7.76
- Return on Invested Capital (ROIC)
- 1322.00%
- Return on Capital Employed (ROCE)
- 13.22
- Revenue Per Employee
- 0
- Profits Per Employee
- -6.03M
- Employee Count
- 2
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Virpax Pharmaceuticals is -0.00. Virpax Pharmaceuticals’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.00
- PB Ratio
- -0.00
- Price to FCF
- -0.00
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Virpax Pharmaceuticals had revenue of 0 and earned -12.07M in profits. Earnings per share was -70.91.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -12.08M
- Pretax Income
- -12.07M
- Net Income
- -12.07M
- EBITDA
- -11.96M
- Earnings Per Share (EPS)
- -70.91
Cash Flow
In the last 12 months, operating cash flow was -16.71M and capital expenditures 0, giving a free cash flow of -16.71M billion.
- Operating Cash Flow
- -16.71M
- Free Cash Flow
- -16.71M
- Free Cash Flow per Share
- -3928.38
Dividends & Yields
Virpax Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1344561544.65%
- Earnings Yield
- -283640.85%
Stock Price Statistics
- Beta
- -18113.10
- 52-Week Price Change
- 638.10%
- 50-Day Moving Average
- 0.03
- 200-Day Moving Average
- 0.02
- Relative Strength Index (RSI)
- 99.86
- Average Volume (3m)
- 785
Important Dates
Virpax Pharmaceuticals upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- Aug 18, 2025
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Virpax Pharmaceuticals as a current ratio of 0.63, with Debt / Equity ratio of 0.00%
- Current Ratio
- 0.63
- Quick Ratio
- 0.63
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.13
- Interest Coverage Ratio
- -116.43
Taxes
In the past 12 months, Virpax Pharmaceuticals has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Virpax Pharmaceuticals EV to EBITDA ratio is 0.13, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.13
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Virpax Pharmaceuticals has $1.51M in cash and marketable securities with $0.00 in debt, giving a net cash position of $1.51M billion.
- Cash & Marketable Securities
- $1.51M
- Total Debt
- $0.00
- Net Cash
- $1.51M
- Net Cash Per Share
- $1.22
- Tangible Book Value Per Share
- -$0.21
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Scores
- Smart Score
- ―
- AI Score
- 40
